Insights

News

November 8, 2024

A Party’s False Advertising Statements that it Possesses a Patent on a Product Feature May Give Rise to a Cause of Action Under Section 43 of the Lanham Act
Nixon & Vanderhye is growing again! We are very pleased to welcome two highly skilled IP attorneys as shareholders in the life sciences, pharmaceutical, chemical, and materials science areas. 

September 27, 2024

Third and Ninth Circuit Appellate Courts Provide Guidance on Applying Brulotte and Kimble to Post-Patent Expiration Royalty Payment Agreements

July 12, 2024

FEDERAL CIRCUIT EXPLAINS THE PRELIMINARY INJUNCTION ANALYSIS FOR A CLAIM BROUGHT UNDER THE DEFEND TRADE SECRETS ACT

July 12, 2024

U.S. SUPREME COURT DEEP-SIXES “CHEVRON DEFERENCE”

April 25, 2024

Federal Circuit Provides Guidance for Assessing the “Materiality” and “Intent” Requirements of Inequitable Conduct, Addresses Serial Misconduct

April 19, 2024

Scientific Games Loses Bid to End Walker Process Fraud/Sham Litigation Antitrust Action on Summary Judgment for the Second Time in Ruling that Provides Caveats on IDS Submissions to the USPTO

February 23, 2024

U.S. Patent & Trademark Office Issues Inventorship Guidance for AI-Assisted Inventions

December 28, 2023

USPTO Director Designates as Precedential the PTAB’s Holding on the Standard for Prior Art Determinations Under AIA § 102.

October 18, 2023

A Rule 50 Motion is Not Required to Preserve for Appellate Review a Purely Legal Issue Resolved at Summary Judgment, But Should You Roll the Dice?

October 18, 2023

Is the IPR Time-Bar of 35 U.S.C. § 315(b) Triggered When Service of the Summons and Complaint in a Related Infringement Action is Defective?

September 21, 2023

Federal Circuit Rules on the Proper Scope of Comparison Prior Art for Assessing Design Patent Infringement in a Case of First Impression

How can we help you?